The company has signed a 'supply agreement' with Whyte International to market and distribute it's range of products in various Latin American and European markets, Syncom Healthcare said in a filing to BSE.
Pharma M&As set to gather more steam in 2013: report
Whyte International is a part of UK-based Whyte Group which has global sourcing services footprints across Europe, Asia, Middle East and Latin America, it added.
Syncom healthcare is a pharmaceutical company which markets and manufactures its products and also undertakes contract manufacturing for various multinationals.
Shares of Syncom Healthcare today closed at Rs 30.25 per scrip on BSE, up 2.89 per cent from its previous close.
Whyte International is a part of UK-based Whyte Group which has global sourcing services footprints across Europe, Asia, Middle East and Latin America, it added.
Syncom healthcare is a pharmaceutical company which markets and manufactures its products and also undertakes contract manufacturing for various multinationals.
Shares of Syncom Healthcare today closed at Rs 30.25 per scrip on BSE, up 2.89 per cent from its previous close.
No comments:
Post a Comment
Please feel free to contact or comment the article